Fig. 3: Meta-analysis of randomized-controlled trials evaluating combinatorial pharmacogenomic testing.

A Meta-analysis of symptom improvement. B Meta-analysis of response. C Meta-analysis of remission.
A Meta-analysis of symptom improvement. B Meta-analysis of response. C Meta-analysis of remission.